SUBSCRIBE
SUBSCRIBE
News   Business

Summit Corporation in $10 Million Infectious Diseases Collaboration

July 24, 2007 | 
1 min read

LONDON (Thomson Financial) - British biotechnology group Summit Corporation PLC, until last week called VASTox, has signed a three-year agreement with Evolva Biotech SA to develop new drugs for infectious diseases.

Alliances Europe
MORE ON THIS TOPIC
Handshake gesture contemporary collage art. Celebrating success, congratulating for financial and business partnership, job contract deal, mutual friendship and respect. Abstract illustration isolated.
Mergers & acquisitions
Nasdaq Neophytes Acelyrin, Alumis Merge to Tackle Immune-Mediated Diseases
February 7, 2025
 · 
2 min read
 · 
Tristan Manalac
Tension, separation, danger or risk concepts. Frayed rope is about to brake on blue background with copy space.
Legal
Regeneron Sues Sanofi, Alleging Stonewalling in Dupixent Pact
February 7, 2025
 · 
2 min read
 · 
Tristan Manalac
Man falls off skis, flat vector illustration isolated on white background. Person learns skiing and falls. Winter sport and vacation activities. Ski resort concept.
Earnings
After Lilly Powers Up Zepbound Supply, Analyst Wonders if Build-Out Is ‘Over Our Skis’
February 6, 2025
 · 
3 min read
 · 
Annalee Armstrong
Concept art to depict schizophrenia and split personality disorder
Schizophrenia
BMS’ Cobenfy Sales Begin, With Launch Full Speed Ahead
February 6, 2025
 · 
2 min read
 · 
Annalee Armstrong